Comparable efficacy and safety of taletrectinib for advanced ROS1+ non–small cell lung cancer across pivotal studies and between races and world regions.

Authors: Maurice Perol, Wei Li, Nathan A. Pennell, Geoffrey Liu, Filippo Guglielmo Maria De Braud, Misako Nagasaka, Enriqueta Felip, Anwen Xiong, Yongchang Zhang, Huijie Fan, Xicheng Wang, Ran Feiwu, Xianyu Zhang, Wenfeng Chen, Wei Wang, Lyudmila Bazhenova, Caicun Zhou

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.8643

Source: Full article

---

Abstract

8643